Valuation: IRIDEX Corporation

Market Cap 15.49M 13.42M 12.57M 11.47M 21.58M 1.48B 21.94M 147M 57.73M 739M 58.15M 56.89M 2.47B P/E 2026 *
-17.8x
P/E 2027 * 44.5x
Enterprise Value 15.49M 13.42M 12.57M 11.47M 21.58M 1.48B 21.94M 147M 57.73M 739M 58.15M 56.89M 2.47B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.27x
Free-Float
62.93%
Yield 2026 *
-
Yield 2027 * -
1 day-5.48%
1 week+0.88%
Current month+3.84%
1 month-20.42%
3 months-18.12%
6 months-38.30%
Current year-25.31%
1 week 0.82
Extreme 0.824
0.93
1 month 0.8
Extreme 0.8041
1.1
Current year 0.8
Extreme 0.8041
1.65
1 year 0.8
Extreme 0.8041
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.39
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap.
7/10/26 Free

Chief Financial Officer

200,000 1.1490%
7/10/26 Free

Chief Executive Officer

400,000 2.2980%
6/13/26 Tax

Chief Executive Officer

-3,990 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
-5.53%+0.88%-34.50%-43.23% 15.49M
-0.87%+3.93%+25.79%+11.14% 224B
-1.56%+2.22%-0.79%-20.64% 146B
-0.60%+6.34%-16.56%+30.78% 142B
-1.31%+5.61%-50.88%-1.77% 74.19B
-1.71%+3.80%+20.04%+14.68% 53.99B
-1.11%+0.05%-15.15%-16.66% 50.85B
-0.36%+5.31%+26.66%+17.33% 42.22B
-0.04%+3.36%+44.80%+43.37% 40.75B
-1.44%+1.71%-3.99%-0.50% 32.86B
Average -1.55%+5.62%-0.46%+3.45% 80.61B
Weighted average by Cap. -1.10%+6.23%+3.30%+7.62%

Financials

2026 *2027 *
Net sales 53M 45.93M 43M 39.23M 73.83M 5.06B 75.07M 504M 198M 2.53B 199M 195M 8.44B 56.77M 49.19M 46.05M 42.02M 79.07M 5.41B 80.4M 540M 212M 2.71B 213M 208M 9.04B
Net income -795K -689K -645K -588K -1.11M -75.83M -1.13M -7.56M -2.96M -37.95M -2.98M -2.92M -127M 361K 313K 293K 267K 503K 34.43M 511K 3.43M 1.35M 17.23M 1.36M 1.33M 57.5M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-08-12 US$0.8406 -5.53% 22,570
26-08-11 US$0.8898 +5.69% 74,086
26-08-10 US$0.8419 +1.37% 66,681
26-08-07 US$0.8305 -1.08% 25,300
26-08-06 US$0.8396 -0.53% 12,827
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8898USD
Average target price
2.750USD
Spread / Average Target
+209.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock